Prevention of osteoporosis with the use of the product of specialized medical nutrition

Cover Page


Cite item

Full Text

Abstract

Aim. To study the efficacy of shellfish dry extract with «Calcium-reparative» filler as a product of specialized medical nutrition to optimize bone metabolism.

Methods. Total of 44 female patients aged from 49 to 71 years, mean age of 54.5±3.8 years, with a combination of several osteoporosis risk factors were involved. 72.7% of all patients complained of pain of varying severity in major joints, in the thoracic and lumbar spine. The patients were randomly divided into two groups - study group (29 patients) and control group (15 patients). Within 30 days, the participants of the study group received «Calcium-reparative» - a product created on the basis of natural biologically active compounds isolated from Far Eastern marine shellfish and purified Altai Shilajit. The efficacy of the product was assessed by means of standard questionnaires for the assessment of quality of life, 10-point visual analogue scale, biochemical laboratory tests. Measurement of serum osteocalcin was performed by ELISA, and immunochemical method - N-terminal propeptide of procollagen type I (the biomarker of bone tissue metabolism).

Results. Adverse and allergic reactions to the product were not registered. Among those receiving the product 37.9% noted improvement of well-being and reduction of pain intensity from 6.9±0.45 to 4.28±0.74 points. In those receiving «Calcium-reparative» the level of synthesis of osteocalcin in the study group did not statistically significantly change and appeared to be 18.6±3.8 ng/ml. The increase in the concentration of procollagen type I from 20.9±3.0 ng/ml prior to administration of the therapeutic product to 37.6±5.8 ng/ml (t=0.006, p ≤0.001) after its administration was observed.

Conclusion. Product of medical nutrition «Calcium-reparative» has the ability to stimulate the cells of bone tissue to synthesize bone matrix protein collagen type I.

About the authors

S N Beniova

Far-Eastern Federal University; Regional Clinical hospital №2

Author for correspondence.
Email: lme@list.ru

P F Kiku

Far-Eastern Federal University

Email: lme@list.ru

B I Gel’tser

Far-Eastern Federal University

Email: lme@list.ru

M V Bobyleva

Regional Clinical hospital №2

Email: lme@list.ru

E V Korableva

Far-Eastern Federal University

Email: lme@list.ru

I G Starodumov

LLC «Zdrava»

Email: lme@list.ru

A B Kolesnikov

LLC «Zdrava»

Email: lme@list.ru

V G Moreva

Far-Eastern Federal University

Email: lme@list.ru

I O Shekunova

Far-Eastern Federal University

Email: lme@list.ru

References

  1. Воронина Н.В., Агиевич Т.Б. Оценка метаболизма костной ткани у больных оксалатной нефропатией с 1-й и 2-й стадией хронической болезни почек. Дальневосточ. мед. ж. 2014; (1): 31-34.
  2. Гависова А.А., Твердикова М.А., Якушевская О.В. Остеопороз: современный взгляд на проблему. Рус. мед. ж. 2012; 20 (21): 1110-1116.
  3. Ершова О.Б., Белова К.Ю., Конопляник Н.В. Клиническая эффективность нового лечебно-профилактического молочного продукта для профилактики остеопороза. Научно-практич. ревматол. 2005; (1): 31-35.
  4. Ковальчук В.К., Иванова И.Л. Особенности обеспечения кальцием, магнием и фосфором населения в Приморском крае. Гигиена и санитария. 2011; (1): 61-66.
  5. Ларина В.Н., Барт Б.Я., Головко М.Г., Распопова Т.Н. Остеопороз в практике врача-терапевта. Пробл. женского здоровья. 2012; 7 (2): 65-72.
  6. Петров В.И., Недогода С.В. Медицина, основанная на доказательствах. Учебное пособие. М.: ГЭОТАР-Медиа. 2012; 144 с.
  7. Савельева К.А., Котова С.М., Орешко Л.С., Колосков В.А. Остеопороз как проблема общей врачебной практики. Проф. и клинич. мед. 2011; 4 (41): 106-109.
  8. Филиппенко Н.Г., Поветкин С.В. Методические основы проведения клинических исследований и статистической обработки полученных данных. Курск. 2010; 26 с.
  9. Bolland M.J., Grey A., Avenell A. et al. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ. 2011; 19: 342. http://dx.doi.org/10.1136/bmj.d2040
  10. Chee W.S., Suriah A.R., Chan S.P. et al. The effects of milk supplementation on bone mineral density in postmenopausal Chinese women in Malaysia. Osteopor. Int. 2003; 14 (10): 828-834. http://dx.doi.org/10.1007/s00198-003-1448-6
  11. Cleghorn D.B., O’Loughlin P.D., Schroeder B.J., Nordin B.E. An open, crossover trial of calcium-fortified milk in prevention of early postmenopausal bone loss. Med. J. Aust. 2001; 175 (5): 242-245.
  12. Gunn C.A., Weber J.L., Kruger M.C. Midlife women, bone health, vegetables, herbs and fruit study. The Scarborough Fair study protocol. BMC Public Health. 2013; 13: 23. http://dx.doi.org/10.1186/1471-2458-13-23
  13. Luo L., Xia W., Sun Y. et al. Association of ESR1 and C6ORF97 gene polymorphism with osteoporosis in postmenopausal women. Mol. Biol. Reports. 2014; 41 (5): 3235-3243. http://dx.doi.org/10.1007/s11033-014-3186-6

Supplementary files

Supplementary Files
Action
1. JATS XML

© 2016 Beniova S.N., Kiku P.F., Gel’tser B.I., Bobyleva M.V., Korableva E.V., Starodumov I.G., Kolesnikov A.B., Moreva V.G., Shekunova I.O.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies